Press Releases from cerbomed GmbH (19 total)
Pharmaceuticals and medical technology will go hand in hand in future – DESITI …
ERLANGEN/HAMBURG, September 17th, 2015 – The medical technology company cerbomed GmbH from Erlangen and the pharmaceutical company DESITIN Arzneimittel GmbH from Hamburg have entered into…
transcutaneous Vagus Nerve Stimulation for epilepsies now available in Norway
ERLANGEN/DRAMMEN, May 28th, 2015 – To address the Norwegian market with transcutaneous Vagus Nerve Stimulation (t-VNS), the medical device company cerbomed from Erlangen, Germany, is…
Vagus nerve stimulation without surgery now available in Denmark, Finland and Sw …
ERLANGEN/AALBORG, Mai 28th, 2015 – More than 30 percent of all epilepsy patients still suffer from continued occurrence of seizures, despite appropriate treatment with…
Trial results for transcutaneous Vagus Nerve Stimulation in pharmacoresistant ep …
ERLANGEN/DRESDEN, 30th April 2015 – At the 9th annual joint conference of the three German-speaking regions of the International League Against Epilepsy in Dresden, the…
Cerbomed GmbH at the 11th European Congress on Epileptology in Stockholm
ERLANGEN/STOCKHOLM, 30.06.2014 – From June 30th until July 3rd 2014 the medical device company cerbomed GmbH from Erlangen, Germany, will present a further therapy option…
Cerbomed GmbH at the 30th International Congress of Clinical Neurophysiology
ERLANGEN/BERLIN, 13.03.2014 – From March 19th until 23rd 2014 the medical device company cerbomed GmbH from Erlangen, Germany, will present the transcutaneous Vagus Nerve Stimulation…
Cerbomed GmbH at the 86th Congress of the German Society of Neurology
ERLANGEN/DRESDEN, Germany, September 12th, 2013 – At the 86th congress of the German Society of Neurology in Dresden the medical device company cerbomed GmbH, Erlangen,…
Cerbomed at the INS 11th World Congress in Berlin
ERLANGEN/BERLIN, Germany, June 6th 2013 – Between June 9th and 12th, 2013, the German medical device company cerbomed GmbH will present another therapy option…
Cerbomed GmbH presents transcutaneous Vagus Nerve Stimulation at the 8th annual …
ERLANGEN/BERLIN, Germany, November 20th, 2012 – Between November 23rd and 24th, 2012 the medical device company cerbomed GmbH, Erlangen, Germany will present the transcutaneous Vagus…
Cerbomed GmbH at the 35th Congress of the German Society of Neurology
ERLANGEN/HAMBURG, Germany, September 24th, 2012 – Between September 26th and 29th, 2012 the medical device company cerbomed GmbH from Erlangen, Germany will present the transcutaneous…
Cerbomed GmbH: Start of a multi-center trial into t-VNS for drug-resistant epile …
ERLANGEN/KEHL-KORK, June 21st, 2012 – the medical device company cerbomed GmbH, Erlangen, Germany and the Epilepsy Center Kork, Germany announce the inclusion of the first…
Cerbomed GmbH: First patient included in the chronic migraine trial
ERLANGEN/MUNICH, May 22nd, 2012 – The medical device company cerbomed GmbH, Erlangen, and the Headache Center of the Neurological Department at the Großhadern Hospital in…
A renewed web presence for cerbomed GmbH
ERLANGEN, Germany, March 8th, 2012 – The German medical device company cerbomed GmbH is re-launching its web site. At www.cerbomed.com patients and their families, as…
Cerbomed GmbH at the 10th annual meeting of the Austrian Society for Neurology ( …
ERLANGEN/GRAZ, Germany, Austria, March 8th, 2012 – Between March 14th and 17th, 2012 cerbomed GmbH will present the transcutaneous Vagus Nerve Stimulation (t-VNS) with NEMOS…
Cerbomed at the 51st annual conference of the German Society for Epileptology
ERLANGEN/STUTTGART, Germany, February 23rd, 2012 – Between February 29th and March 3rd, 2012 cerbomed GmbH will introduce the transcutaneous Vagus Nerve Stimulation (t-VNS) with NEMOS…
Expertise in epilepsy treatment: Prof. Dr. med. Hajo Hamer reinforces the scient …
ERLANGEN, Germany, 21.02.2012 – In Prof. Dr. Hajo Hamer the medical device company cerbomed GmbH gains a renowned expert in epileptology for its scientific advisory…
Cerbomed at the 4th International Epilepsy Colloquium in Marburg
ERLANGEN, Germany, 24.06.2011 – The medical device company cerbomed GmbH is proud to present NEMOS, the world’s first medical device for transcutaneous Vagus Nerve Stimulation…
cerbomed gets CE labeling for transcutaneous vagus nerve stimulator
Erlangen, May 12th, 2010. cerbomed gmbh, a start-up company in the area of neuro-stimulation, today announced that its transcutaneous vagus nerve stimulator now has the…
cerboMed appoints Christoph A. Bally as Chief Executive Officer
Erlangen, Mai 30, 2009. cerboMed GmbH, a medical device company focused on innovative neurostimulation technologies, has appointed Christoph Bally as the company’s Chief Executive Officer…
Go To Page:
